• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

衰老对 6-OHDA 诱导的帕金森病大鼠模型的影响。

Impact of Aging on the 6-OHDA-Induced Rat Model of Parkinson's Disease.

机构信息

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal.

ICVS/3B's-PT Government Associate Laboratory, 4710-057/4805-017 Braga/Guimarães, Portugal.

出版信息

Int J Mol Sci. 2020 May 14;21(10):3459. doi: 10.3390/ijms21103459.

DOI:10.3390/ijms21103459
PMID:32422916
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7279033/
Abstract

Parkinson's disease (PD) is the second most common age-related neurodegenerative disorder. The neurodegeneration leading to incapacitating motor abnormalities mainly occurs in the nigrostriatal pathway due to the loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc). Several animal models have been developed not only to better understand the mechanisms underlying neurodegeneration but also to test the potential of emerging disease-modifying therapies. However, despite aging being the main risk factor for developing idiopathic PD, most of the studies do not use aged animals. Therefore, this study aimed at assessing the effect of aging in the unilateral 6-hydroxydopamine (6-OHDA)-induced animal model of PD. For this, female young adult and aged rats received a unilateral injection of 6-OHDA into the medial forebrain bundle. Subsequently, the impact of aging on 6-OHDA-induced effects on animal welfare, motor performance, and nigrostriatal integrity were assessed. The results showed that aging had a negative impact on animal welfare after surgery. Furthermore, 6-OHDA-induced impairments on skilled motor function were significantly higher in aged rats when compared with their younger counterparts. Nigrostriatal histological analysis further revealed an increased 6-OHDA-induced dopaminergic cell loss in the SNpc of aged animals when compared to young animals. Overall, our results demonstrate a higher susceptibility of aged animals to 6-OHDA toxic insult.

摘要

帕金森病(PD)是第二常见的与年龄相关的神经退行性疾病。导致致残性运动异常的神经退行性变主要发生在黑质纹状体通路,因为黑质致密部(SNpc)中的多巴胺能神经元丧失。已经开发了几种动物模型,不仅可以更好地了解神经退行性变的机制,还可以测试新兴的疾病修饰疗法的潜力。然而,尽管衰老是导致特发性 PD 的主要危险因素,但大多数研究都不使用老年动物。因此,本研究旨在评估衰老对单侧 6-羟多巴胺(6-OHDA)诱导的 PD 动物模型的影响。为此,年轻成年和老年雌性大鼠接受了内侧前脑束的单侧 6-OHDA 注射。随后,评估了衰老对 6-OHDA 诱导的动物福利、运动表现和黑质纹状体完整性的影响。结果表明,衰老对手术后动物福利有负面影响。此外,与年轻大鼠相比,6-OHDA 诱导的熟练运动功能障碍在老年大鼠中更为严重。黑质纹状体组织学分析进一步显示,与年轻动物相比,老年动物的 SNpc 中 6-OHDA 诱导的多巴胺能神经元丧失增加。总的来说,我们的结果表明,老年动物对 6-OHDA 毒性损伤的易感性更高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e37/7279033/461e70c2d55c/ijms-21-03459-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e37/7279033/a070997cbfb7/ijms-21-03459-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e37/7279033/2ea2c06a8fd1/ijms-21-03459-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e37/7279033/96eebf409509/ijms-21-03459-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e37/7279033/ede03c8ce36b/ijms-21-03459-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e37/7279033/461e70c2d55c/ijms-21-03459-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e37/7279033/a070997cbfb7/ijms-21-03459-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e37/7279033/2ea2c06a8fd1/ijms-21-03459-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e37/7279033/96eebf409509/ijms-21-03459-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e37/7279033/ede03c8ce36b/ijms-21-03459-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e37/7279033/461e70c2d55c/ijms-21-03459-g005.jpg

相似文献

1
Impact of Aging on the 6-OHDA-Induced Rat Model of Parkinson's Disease.衰老对 6-OHDA 诱导的帕金森病大鼠模型的影响。
Int J Mol Sci. 2020 May 14;21(10):3459. doi: 10.3390/ijms21103459.
2
Fibroblast growth factor-20 protects against dopamine neuron loss in vitro and provides functional protection in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.成纤维细胞生长因子 20 可防止体外多巴胺神经元丢失,并在帕金森病的 6-羟多巴胺损伤大鼠模型中提供功能保护。
Neuropharmacology. 2012 Dec;63(7):1268-77. doi: 10.1016/j.neuropharm.2012.07.029. Epub 2012 Aug 10.
3
Extracellular Zn Influx into Nigral Dopaminergic Neurons Plays a Key Role for Pathogenesis of 6-Hydroxydopamine-Induced Parkinson's Disease in Rats.细胞外锌流入黑质多巴胺能神经元在大鼠 6-羟多巴胺诱导的帕金森病发病机制中起关键作用。
Mol Neurobiol. 2019 Jan;56(1):435-443. doi: 10.1007/s12035-018-1075-z. Epub 2018 Apr 29.
4
Characterization of graded 6-Hydroxydopamine unilateral lesion in medial forebrain bundle of mice.小鼠内侧前脑束分级 6-羟多巴胺单侧损伤的特征。
Sci Rep. 2024 Feb 14;14(1):3721. doi: 10.1038/s41598-024-54066-0.
5
Effects of bromelain on motor responses following intra-medial forebrain bundle 6-OHDA injection in rat model of parkinsonism.菠萝蛋白酶对帕金森病大鼠模型内侧隔核 6-OHDA 注射后运动反应的影响。
Metab Brain Dis. 2019 Dec;34(6):1557-1564. doi: 10.1007/s11011-019-00462-9. Epub 2019 Jul 22.
6
Neuroprotective Effect of Curcumin on the Nigrostriatal Pathway in a 6-Hydroxydopmine-Induced Rat Model of Parkinson's Disease is Mediated by α7-Nicotinic Receptors.姜黄素通过α7-烟碱型乙酰胆碱受体对 6-羟多巴胺诱导的帕金森病大鼠黑质纹状体通路的神经保护作用。
Int J Mol Sci. 2020 Oct 3;21(19):7329. doi: 10.3390/ijms21197329.
7
Establishment of a 6-OHDA Induced Unilaterally Lesioned Male Wistar Rat Model of Parkinson's Disease.建立单侧损毁单侧损毁 6-OHDA 诱导的帕金森病雄性 Wistar 大鼠模型。
Methods Mol Biol. 2024;2761:491-498. doi: 10.1007/978-1-0716-3662-6_33.
8
Acetyl-l-carnitine protects dopaminergic nigrostriatal pathway in 6-hydroxydopamine-induced model of Parkinson's disease in the rat.乙酰左旋肉碱可保护大鼠 6-羟多巴胺诱导的帕金森病模型中的多巴胺能黑质纹状体通路。
Biomed Pharmacother. 2017 May;89:1-9. doi: 10.1016/j.biopha.2017.02.007. Epub 2017 Feb 12.
9
Hesperidin Ameliorates Anxiety-Depressive-Like Behavior in 6-OHDA Model of Parkinson's Disease by Regulating Striatal Cytokine and Neurotrophic Factors Levels and Dopaminergic Innervation Loss in the Striatum of Mice.橙皮苷通过调节纹状体细胞因子和神经营养因子水平以及多巴胺能神经支配丢失改善 6-OHDA 帕金森病模型中小鼠的焦虑-抑郁样行为。
Mol Neurobiol. 2020 Jul;57(7):3027-3041. doi: 10.1007/s12035-020-01940-3. Epub 2020 May 26.
10
The Kv7/KCNQ channel blocker XE991 protects nigral dopaminergic neurons in the 6-hydroxydopamine rat model of Parkinson's disease.Kv7/KCNQ 通道阻断剂 XE991 可保护帕金森病 6-羟多巴胺大鼠模型中的黑质多巴胺能神经元。
Brain Res Bull. 2018 Mar;137:132-139. doi: 10.1016/j.brainresbull.2017.11.011. Epub 2017 Nov 22.

引用本文的文献

1
The current approaches to modeling the brain ischemia-reperfusion and inflammation: from animal models toward vascularized and neuroimmune cerebral organoids.目前模拟脑缺血再灌注和炎症的方法:从动物模型到血管化和神经免疫性脑类器官。
Rev Neurosci. 2025 May 28. doi: 10.1515/revneuro-2025-0015.
2
Mechanism of Action and Therapeutic Potential of Xanthohumol in Prevention of Selected Neurodegenerative Diseases.黄腐酚预防特定神经退行性疾病的作用机制及治疗潜力
Molecules. 2025 Feb 5;30(3):694. doi: 10.3390/molecules30030694.
3
Challenges and Opportunities in Exploring Non-Motor Symptoms in 6-Hydroxydopamine Models of Parkinson's Disease: A Systematic Review.

本文引用的文献

1
Preclinical Comparison of Stem Cells Secretome and Levodopa Application in a 6-Hydroxydopamine Rat Model of Parkinson's Disease.帕金森病 6-羟多巴胺大鼠模型中干细胞分泌液与左旋多巴应用的临床前比较。
Cells. 2020 Jan 28;9(2):315. doi: 10.3390/cells9020315.
2
Bone Marrow Mesenchymal Stem Cells' Secretome Exerts Neuroprotective Effects in a Parkinson's Disease Rat Model.骨髓间充质干细胞的分泌组在帕金森病大鼠模型中发挥神经保护作用。
Front Bioeng Biotechnol. 2019 Nov 1;7:294. doi: 10.3389/fbioe.2019.00294. eCollection 2019.
3
The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson's disease.
探索帕金森病6-羟基多巴胺模型中非运动症状的挑战与机遇:一项系统评价
J Neurochem. 2025 Feb;169(2):e70008. doi: 10.1111/jnc.70008.
4
Treadmill intervention attenuates motor deficit with 6-OHDA-induced Parkinson's disease rat via changes in lipid profiles in brain and muscle.跑步机干预通过改变大脑和肌肉中的脂质谱来减轻6-羟基多巴胺诱导的帕金森病大鼠的运动功能障碍。
Aging (Albany NY). 2025 Jan 3;17(1):232-250. doi: 10.18632/aging.206181.
5
Aging, Parkinson's Disease, and Models: What Are the Challenges?衰老、帕金森病与模型:面临哪些挑战?
Aging Biol. 2023;1. doi: 10.59368/agingbio.20230010. Epub 2023 Jul 28.
6
The 6-OHDA Parkinson's Disease Mouse Model Shows Deficits in Sensory Behavior.6-羟基多巴胺帕金森病小鼠模型表现出感觉行为缺陷。
bioRxiv. 2025 Jan 29:2024.06.05.597339. doi: 10.1101/2024.06.05.597339.
7
IGFBP5 Promotes Neuronal Apoptosis in a 6-OHDA-Toxicant Model of Parkinson's Disease by Inhibiting the Sonic Hedgehog Signaling Pathway.胰岛素样生长因子结合蛋白5通过抑制音猬因子信号通路促进帕金森病6-羟基多巴胺毒性模型中的神经元凋亡。
Med Princ Pract. 2024;33(3):269-280. doi: 10.1159/000538467. Epub 2024 Apr 2.
8
The Absence of Gastrointestinal Redox Dyshomeostasis in the Brain-First Rat Model of Parkinson's Disease Induced by Bilateral Intrastriatal 6-Hydroxydopamine.脑优先帕金森病大鼠模型中双侧纹状体 6-羟多巴胺诱导的胃肠道氧化还原动态平衡失调缺失。
Mol Neurobiol. 2024 Aug;61(8):5481-5493. doi: 10.1007/s12035-023-03906-7. Epub 2024 Jan 10.
9
Pre-clinical Aspects and Contemporary Treatments of Parkinson's Disease.帕金森病的临床前研究现状与当代治疗策略
CNS Neurol Disord Drug Targets. 2024;23(8):996-1014. doi: 10.2174/0118715273258646230920074421.
10
Uridine as a Regulator of Functional and Ultrastructural Changes in the Brain of Rats in a Model of 6-OHDA-Induced Parkinson's Disease.尿苷作为一种调节剂,调节 6-OHDA 诱导的帕金森病模型大鼠大脑的功能和超微结构变化。
Int J Mol Sci. 2023 Sep 19;24(18):14304. doi: 10.3390/ijms241814304.
衰老、遗传因素与环境因素在帕金森病发病机制中的相互作用。
Transl Neurodegener. 2019 Aug 16;8:23. doi: 10.1186/s40035-019-0165-9. eCollection 2019.
4
Time dependent degeneration of the nigrostriatal tract in mice with 6-OHDA lesioned medial forebrain bundle and the effect of activin A on L-Dopa induced dyskinesia.6-OHDA 损毁内侧前脑束致小鼠黑质纹状体束的时间依赖性退变及激活素 A 对 L-Dopa 诱导运动障碍的影响。
BMC Neurosci. 2019 Feb 13;20(1):5. doi: 10.1186/s12868-019-0487-7.
5
Animal models of neurodegenerative diseases.神经退行性疾病的动物模型。
Nat Neurosci. 2018 Oct;21(10):1370-1379. doi: 10.1038/s41593-018-0236-8. Epub 2018 Sep 24.
6
Secretome of Undifferentiated Neural Progenitor Cells Induces Histological and Motor Improvements in a Rat Model of Parkinson's Disease.未分化神经祖细胞的分泌组可诱导帕金森病大鼠模型的组织学和运动改善。
Stem Cells Transl Med. 2018 Nov;7(11):829-838. doi: 10.1002/sctm.18-0009. Epub 2018 Sep 20.
7
Determinants of dopaminergic neuron loss in Parkinson's disease.帕金森病中多巴胺能神经元丧失的决定因素。
FEBS J. 2018 Oct;285(19):3657-3668. doi: 10.1111/febs.14607. Epub 2018 Aug 14.
8
Effects of Aging in the Striatum and Substantia Nigra of a Parkinson's Disease Animal Model.帕金森病动物模型纹状体和黑质衰老的影响
Toxicol Pathol. 2018 Apr;46(3):348-358. doi: 10.1177/0192623318767065.
9
Disease Modification in Parkinson's Disease: Current Approaches, Challenges, and Future Considerations.帕金森病的疾病修饰:当前方法、挑战和未来考虑。
Mov Disord. 2018 May;33(5):660-677. doi: 10.1002/mds.27360. Epub 2018 Apr 11.
10
Astaxanthin is neuroprotective in an aged mouse model of Parkinson's disease.虾青素在帕金森病老年小鼠模型中具有神经保护作用。
Oncotarget. 2017 Dec 28;9(12):10388-10401. doi: 10.18632/oncotarget.23737. eCollection 2018 Feb 13.